Guidelines of care for th...

For individuals with atopic dermatitis (AD), emollients and prescription topical therapies are generally effective in achieving AD control. However, those with more severe or widespread AD, substantially impaired quality of life (QOL), or AD refractory to optimized topical therapy may explore phototherapy or systemic therapies (including oral medications, injectables, and biologics) to enhance disease control and QOL. The decision to initiate these advanced therapies should involve shared decision-making between patients and clinicians, considering the severity of AD, its impact on the patient, and the efficacy, safety, and accessibility of available interventions.